Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 3031185 safety, tolerability, pharmacokinetics, and oral contraceptive interaction study in healthy Japanese volunteers
jRCT2071260049Suspended
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of BI 3031185 (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Drug-related treatment-emergent adverse events. Started Jun 2026; status: suspended.
02
Drugs
BI 3031185
Beyond the preview
Go deeper on jRCT2071260049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260049.